The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Invasive Glucose Monitoring Market Research Report 2024
Synopsis
Invasive glucose monitoring refers to blood glucose measurement methods that require the collection of a blood sample through finger pricking or other means.
The global Invasive Glucose Monitoring market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The market for invasive glucose monitoring is driven by the widespread use of traditional glucose monitoring methods, such as self-monitoring of blood glucose (SMBG) with glucose meters. While non-invasive glucose monitoring methods are gaining popularity, invasive monitoring remains a dominant and cost-effective approach, especially in resource-constrained settings.
This report aims to provide a comprehensive presentation of the global market for Invasive Glucose Monitoring, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Invasive Glucose Monitoring.
Report Scope
The Invasive Glucose Monitoring market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Invasive Glucose Monitoring market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Invasive Glucose Monitoring manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott
Medtronic
Roche
Bayer AG
B. Braun
Nipro Diagnostics
Life Scan Inc.(J&J)
Arkray Devices
Nova Biomedical
Bionime Corporation
Sinocare
Hybio Pharmaceutical
Lepu Medical
Yuyue Medical
Segment by Type
Wearable Blood Glucose Monitoring Systems
Table Top Blood Glucose Monitoring Systems
Segment by Application
Hospitals
Clinics
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Invasive Glucose Monitoring manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Invasive Glucose Monitoring in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Invasive glucose monitoring refers to blood glucose measurement methods that require the collection of a blood sample through finger pricking or other means.
The global Invasive Glucose Monitoring market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The market for invasive glucose monitoring is driven by the widespread use of traditional glucose monitoring methods, such as self-monitoring of blood glucose (SMBG) with glucose meters. While non-invasive glucose monitoring methods are gaining popularity, invasive monitoring remains a dominant and cost-effective approach, especially in resource-constrained settings.
This report aims to provide a comprehensive presentation of the global market for Invasive Glucose Monitoring, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Invasive Glucose Monitoring.
Report Scope
The Invasive Glucose Monitoring market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Invasive Glucose Monitoring market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Invasive Glucose Monitoring manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott
Medtronic
Roche
Bayer AG
B. Braun
Nipro Diagnostics
Life Scan Inc.(J&J)
Arkray Devices
Nova Biomedical
Bionime Corporation
Sinocare
Hybio Pharmaceutical
Lepu Medical
Yuyue Medical
Segment by Type
Wearable Blood Glucose Monitoring Systems
Table Top Blood Glucose Monitoring Systems
Segment by Application
Hospitals
Clinics
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Invasive Glucose Monitoring manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Invasive Glucose Monitoring in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Invasive Glucose Monitoring Market Overview
1.1 Product Overview and Scope of Invasive Glucose Monitoring
1.2 Invasive Glucose Monitoring Segment by Type
1.2.1 Global Invasive Glucose Monitoring Market Value Comparison by Type (2024-2030)
1.2.2 Wearable Blood Glucose Monitoring Systems
1.2.3 Table Top Blood Glucose Monitoring Systems
1.3 Invasive Glucose Monitoring Segment by Application
1.3.1 Global Invasive Glucose Monitoring Market Value by Application: (2024-2030)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global Invasive Glucose Monitoring Market Size Estimates and Forecasts
1.4.1 Global Invasive Glucose Monitoring Revenue 2019-2030
1.4.2 Global Invasive Glucose Monitoring Sales 2019-2030
1.4.3 Global Invasive Glucose Monitoring Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Invasive Glucose Monitoring Market Competition by Manufacturers
2.1 Global Invasive Glucose Monitoring Sales Market Share by Manufacturers (2019-2024)
2.2 Global Invasive Glucose Monitoring Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Invasive Glucose Monitoring Average Price by Manufacturers (2019-2024)
2.4 Global Invasive Glucose Monitoring Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Invasive Glucose Monitoring, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Invasive Glucose Monitoring, Product Type & Application
2.7 Invasive Glucose Monitoring Market Competitive Situation and Trends
2.7.1 Invasive Glucose Monitoring Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Invasive Glucose Monitoring Players Market Share by Revenue
2.7.3 Global Invasive Glucose Monitoring Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Invasive Glucose Monitoring Retrospective Market Scenario by Region
3.1 Global Invasive Glucose Monitoring Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Invasive Glucose Monitoring Global Invasive Glucose Monitoring Sales by Region: 2019-2030
3.2.1 Global Invasive Glucose Monitoring Sales by Region: 2019-2024
3.2.2 Global Invasive Glucose Monitoring Sales by Region: 2025-2030
3.3 Global Invasive Glucose Monitoring Global Invasive Glucose Monitoring Revenue by Region: 2019-2030
3.3.1 Global Invasive Glucose Monitoring Revenue by Region: 2019-2024
3.3.2 Global Invasive Glucose Monitoring Revenue by Region: 2025-2030
3.4 North America Invasive Glucose Monitoring Market Facts & Figures by Country
3.4.1 North America Invasive Glucose Monitoring Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Invasive Glucose Monitoring Sales by Country (2019-2030)
3.4.3 North America Invasive Glucose Monitoring Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Invasive Glucose Monitoring Market Facts & Figures by Country
3.5.1 Europe Invasive Glucose Monitoring Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Invasive Glucose Monitoring Sales by Country (2019-2030)
3.5.3 Europe Invasive Glucose Monitoring Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Invasive Glucose Monitoring Market Facts & Figures by Country
3.6.1 Asia Pacific Invasive Glucose Monitoring Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Invasive Glucose Monitoring Sales by Country (2019-2030)
3.6.3 Asia Pacific Invasive Glucose Monitoring Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Invasive Glucose Monitoring Market Facts & Figures by Country
3.7.1 Latin America Invasive Glucose Monitoring Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Invasive Glucose Monitoring Sales by Country (2019-2030)
3.7.3 Latin America Invasive Glucose Monitoring Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Invasive Glucose Monitoring Market Facts & Figures by Country
3.8.1 Middle East and Africa Invasive Glucose Monitoring Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Invasive Glucose Monitoring Sales by Country (2019-2030)
3.8.3 Middle East and Africa Invasive Glucose Monitoring Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Invasive Glucose Monitoring Sales by Type (2019-2030)
4.1.1 Global Invasive Glucose Monitoring Sales by Type (2019-2024)
4.1.2 Global Invasive Glucose Monitoring Sales by Type (2025-2030)
4.1.3 Global Invasive Glucose Monitoring Sales Market Share by Type (2019-2030)
4.2 Global Invasive Glucose Monitoring Revenue by Type (2019-2030)
4.2.1 Global Invasive Glucose Monitoring Revenue by Type (2019-2024)
4.2.2 Global Invasive Glucose Monitoring Revenue by Type (2025-2030)
4.2.3 Global Invasive Glucose Monitoring Revenue Market Share by Type (2019-2030)
4.3 Global Invasive Glucose Monitoring Price by Type (2019-2030)
5 Segment by Application
5.1 Global Invasive Glucose Monitoring Sales by Application (2019-2030)
5.1.1 Global Invasive Glucose Monitoring Sales by Application (2019-2024)
5.1.2 Global Invasive Glucose Monitoring Sales by Application (2025-2030)
5.1.3 Global Invasive Glucose Monitoring Sales Market Share by Application (2019-2030)
5.2 Global Invasive Glucose Monitoring Revenue by Application (2019-2030)
5.2.1 Global Invasive Glucose Monitoring Revenue by Application (2019-2024)
5.2.2 Global Invasive Glucose Monitoring Revenue by Application (2025-2030)
5.2.3 Global Invasive Glucose Monitoring Revenue Market Share by Application (2019-2030)
5.3 Global Invasive Glucose Monitoring Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Abbott
6.1.1 Abbott Corporation Information
6.1.2 Abbott Description and Business Overview
6.1.3 Abbott Invasive Glucose Monitoring Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Abbott Invasive Glucose Monitoring Product Portfolio
6.1.5 Abbott Recent Developments/Updates
6.2 Medtronic
6.2.1 Medtronic Corporation Information
6.2.2 Medtronic Description and Business Overview
6.2.3 Medtronic Invasive Glucose Monitoring Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Medtronic Invasive Glucose Monitoring Product Portfolio
6.2.5 Medtronic Recent Developments/Updates
6.3 Roche
6.3.1 Roche Corporation Information
6.3.2 Roche Description and Business Overview
6.3.3 Roche Invasive Glucose Monitoring Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Roche Invasive Glucose Monitoring Product Portfolio
6.3.5 Roche Recent Developments/Updates
6.4 Bayer AG
6.4.1 Bayer AG Corporation Information
6.4.2 Bayer AG Description and Business Overview
6.4.3 Bayer AG Invasive Glucose Monitoring Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Bayer AG Invasive Glucose Monitoring Product Portfolio
6.4.5 Bayer AG Recent Developments/Updates
6.5 B. Braun
6.5.1 B. Braun Corporation Information
6.5.2 B. Braun Description and Business Overview
6.5.3 B. Braun Invasive Glucose Monitoring Sales, Revenue and Gross Margin (2019-2024)
6.5.4 B. Braun Invasive Glucose Monitoring Product Portfolio
6.5.5 B. Braun Recent Developments/Updates
6.6 Nipro Diagnostics
6.6.1 Nipro Diagnostics Corporation Information
6.6.2 Nipro Diagnostics Description and Business Overview
6.6.3 Nipro Diagnostics Invasive Glucose Monitoring Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Nipro Diagnostics Invasive Glucose Monitoring Product Portfolio
6.6.5 Nipro Diagnostics Recent Developments/Updates
6.7 Life Scan Inc.(J&J)
6.6.1 Life Scan Inc.(J&J) Corporation Information
6.6.2 Life Scan Inc.(J&J) Description and Business Overview
6.6.3 Life Scan Inc.(J&J) Invasive Glucose Monitoring Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Life Scan Inc.(J&J) Invasive Glucose Monitoring Product Portfolio
6.7.5 Life Scan Inc.(J&J) Recent Developments/Updates
6.8 Arkray Devices
6.8.1 Arkray Devices Corporation Information
6.8.2 Arkray Devices Description and Business Overview
6.8.3 Arkray Devices Invasive Glucose Monitoring Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Arkray Devices Invasive Glucose Monitoring Product Portfolio
6.8.5 Arkray Devices Recent Developments/Updates
6.9 Nova Biomedical
6.9.1 Nova Biomedical Corporation Information
6.9.2 Nova Biomedical Description and Business Overview
6.9.3 Nova Biomedical Invasive Glucose Monitoring Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Nova Biomedical Invasive Glucose Monitoring Product Portfolio
6.9.5 Nova Biomedical Recent Developments/Updates
6.10 Bionime Corporation
6.10.1 Bionime Corporation Corporation Information
6.10.2 Bionime Corporation Description and Business Overview
6.10.3 Bionime Corporation Invasive Glucose Monitoring Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Bionime Corporation Invasive Glucose Monitoring Product Portfolio
6.10.5 Bionime Corporation Recent Developments/Updates
6.11 Sinocare
6.11.1 Sinocare Corporation Information
6.11.2 Sinocare Invasive Glucose Monitoring Description and Business Overview
6.11.3 Sinocare Invasive Glucose Monitoring Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Sinocare Invasive Glucose Monitoring Product Portfolio
6.11.5 Sinocare Recent Developments/Updates
6.12 Hybio Pharmaceutical
6.12.1 Hybio Pharmaceutical Corporation Information
6.12.2 Hybio Pharmaceutical Invasive Glucose Monitoring Description and Business Overview
6.12.3 Hybio Pharmaceutical Invasive Glucose Monitoring Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Hybio Pharmaceutical Invasive Glucose Monitoring Product Portfolio
6.12.5 Hybio Pharmaceutical Recent Developments/Updates
6.13 Lepu Medical
6.13.1 Lepu Medical Corporation Information
6.13.2 Lepu Medical Invasive Glucose Monitoring Description and Business Overview
6.13.3 Lepu Medical Invasive Glucose Monitoring Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Lepu Medical Invasive Glucose Monitoring Product Portfolio
6.13.5 Lepu Medical Recent Developments/Updates
6.14 Yuyue Medical
6.14.1 Yuyue Medical Corporation Information
6.14.2 Yuyue Medical Invasive Glucose Monitoring Description and Business Overview
6.14.3 Yuyue Medical Invasive Glucose Monitoring Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Yuyue Medical Invasive Glucose Monitoring Product Portfolio
6.14.5 Yuyue Medical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Invasive Glucose Monitoring Industry Chain Analysis
7.2 Invasive Glucose Monitoring Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Invasive Glucose Monitoring Production Mode & Process
7.4 Invasive Glucose Monitoring Sales and Marketing
7.4.1 Invasive Glucose Monitoring Sales Channels
7.4.2 Invasive Glucose Monitoring Distributors
7.5 Invasive Glucose Monitoring Customers
8 Invasive Glucose Monitoring Market Dynamics
8.1 Invasive Glucose Monitoring Industry Trends
8.2 Invasive Glucose Monitoring Market Drivers
8.3 Invasive Glucose Monitoring Market Challenges
8.4 Invasive Glucose Monitoring Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
